“Nothing has changed in terms of the clinical effectiveness of these treatments. They remain as clinically effective now as they were when they were added to the list of funded drugs. We understand the financial pressures that the NHS is under, but these changes will restrict patients’ ability to choose treatments that we have seen extend lives and will reduce a clinician’s ability to prescribe treatments according to a patient’s clinical need.